Drug Tales and Other Stories

Reading up on drug companies: there in black and white

BMJ 2010; 341 doi: 10.1136/bmj.c5626 (Published 12 October 2010)
Cite this as: BMJ 2010;341:c5626

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Ike Iheanacho, editor, Drug and Therapeutics Bulletin
  1. iiheanacho{at}bmjgroup.com

Say you wanted to keep a casual eye on what the drug industry was up to: where could you look? For the enthusiast, there’s a myriad trade publications, websites, news feeds, and blogs to cater to this need. These, though, may hold little appeal for healthcare professionals, who’d rather remain amateurs in this particular area.

They might try instead general medical journals. But coverage there tends to be tangential and, sometimes, distorting, through its selective focus on individual drugs or conditions. And where the industry, …

Access to the full text of this article requires a subscription or payment

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL